• M*******h has spent nearly $20 million on R&D since 2002;
• M*******h has 12 collaborative studies scheduled for completion in 2007. These studies include: 6 randomized, placebo-controlled trials; 3 laboratory projects and 3 open-label trials.
• M*******h will submit 3 completed clinical trials to major journals for publication in 2007.